Phenotypic Assay

Table P1. Single Targets Enriched Among Active molecules

  • kA:The number of active compounds known to target the gene
  • KA:The total number of active compounds(IC50 < 10-6)
  • kB:The number of inactive compounds known to target the gene
  • KB:The total number of inactive compounds(IC50 >10-6)

  • Odds Ratio: (kA/kB) / ( (KA-kA) / (KB - kB) )
# Target (Gene) P-value
FDR adjusted		 Odds Ratio kA KA kB KB Polypharmacology
report		 View
Compounds
details		 View Target Profile
1 TNFSF10 1.36e-50 311.8 31 338 9 27803 Polypharmacology Molecules Target Profile
2 TNFRSF10B 9.94e-72 72.1 57 338 78 27803 Polypharmacology Molecules Target Profile
3 MMP14 1.17e-14 33.3 14 338 36 27803 Polypharmacology Molecules Target Profile
4 CASP3 3.61e-41 28.6 43 338 141 27803 Polypharmacology Molecules Target Profile
5 NFKB1 6.19e-11 28.3 11 338 33 27803 Polypharmacology Molecules Target Profile
6 SENP7 1.54e-43 24.0 49 338 195 27803 Polypharmacology Molecules Target Profile
7 SENP6 3.61e-41 21.9 48 338 209 27803 Polypharmacology Molecules Target Profile
8 HSP90AA1 2.00e-19 21.7 22 338 89 27803 Polypharmacology Molecules Target Profile
9 SENP8 4.52e-41 20.7 49 338 226 27803 Polypharmacology Molecules Target Profile
10 STAT3 6.78e-28 16.9 36 338 195 27803 Polypharmacology Molecules Target Profile
11 SMN2 7.16e-64 14.9 94 338 703 27803 Polypharmacology Molecules Target Profile
12 NPC1 1.40e-30 14.4 43 338 278 27803 Polypharmacology Molecules Target Profile
13 NR0B1 7.15e-21 14.2 29 338 182 27803 Polypharmacology Molecules Target Profile
14 EPAS1 2.55e-10 14.1 14 338 85 27803 Polypharmacology Molecules Target Profile
15 APP 1.93e-20 13.6 29 338 190 27803 Polypharmacology Molecules Target Profile
16 RAB9A 3.15e-34 13.2 51 338 370 27803 Polypharmacology Molecules Target Profile
17 MITF 2.71e-09 11.5 14 338 104 27803 Polypharmacology Molecules Target Profile
18 STAT1 2.89e-24 10.7 40 338 343 27803 Polypharmacology Molecules Target Profile
19 NOD1 0.00033 5.5 10 338 154 27803 Polypharmacology Molecules Target Profile
20 MTOR 6.09e-06 3.8 22 338 497 27803 Polypharmacology Molecules Target Profile
21 IDH1 0.00026 3.7 16 338 373 27803 Polypharmacology Molecules Target Profile
22 GMNN 0.00033 3.1 19 338 517 27803 Polypharmacology Molecules Target Profile
23 ATAD5 6.71e-05 3.1 24 338 679 27803 Polypharmacology Molecules Target Profile
24 GALK1 0.0059 82.7 2 338 2 27803 Polypharmacology Molecules Target Profile
25 PTPN22 0.0091 55.2 2 338 3 27803 Polypharmacology Molecules Target Profile
26 PTPN7 0.021 27.6 2 338 6 27803 Polypharmacology Molecules Target Profile
27 LHCGR 0.16 27.5 1 338 3 27803 Polypharmacology Molecules Target Profile
28 PAFAH1B3 0.00012 20.9 5 338 20 27803 Polypharmacology Molecules Target Profile
29 TNKS2 0.19 20.6 1 338 4 27803 Polypharmacology Molecules Target Profile
30 KDM4C 0.19 20.6 1 338 4 27803 Polypharmacology Molecules Target Profile
31 NCOA1 0.00093 19.6 4 338 17 27803 Polypharmacology Molecules Target Profile
32 LYPLA1 0.0068 17.8 3 338 14 27803 Polypharmacology Molecules Target Profile
33 NCOA3 7.83e-06 17.3 7 338 34 27803 Polypharmacology Molecules Target Profile
34 HKDC1 0.000307 16.7 5 338 25 27803 Polypharmacology Molecules Target Profile
35 KLF5 0.0013 16.6 4 338 20 27803 Polypharmacology Molecules Target Profile
36 ROCK2 0.22 16.5 1 338 5 27803 Polypharmacology Molecules Target Profile
37 UCHL5 6.50e-05 16.2 6 338 31 27803 Polypharmacology Molecules Target Profile
38 NCOA2 0.000502 14.4 5 338 29 27803 Polypharmacology Molecules Target Profile
39 DUSP1 0.26 13.7 1 338 6 27803 Polypharmacology Molecules Target Profile
40 DCLRE1C 0.058 12.7 2 338 13 27803 Polypharmacology Molecules Target Profile
41 EYA2 0.065 11.8 2 338 14 27803 Polypharmacology Molecules Target Profile
42 MBNL1 0.079 10.3 2 338 16 27803 Polypharmacology Molecules Target Profile
43 DAGLB 0.31 10.3 1 338 8 27803 Polypharmacology Molecules Target Profile
44 VCP 0.024 10.0 3 338 25 27803 Polypharmacology Molecules Target Profile
45 PPP5C 0.085 9.7 2 338 17 27803 Polypharmacology Molecules Target Profile
46 AGTR1 0.32 9.2 1 338 9 27803 Polypharmacology Molecules Target Profile
47 CTSL1 0.00095 8.8 6 338 57 27803 Polypharmacology Molecules Target Profile
48 S1PR1 0.098 8.7 2 338 19 27803 Polypharmacology Molecules Target Profile
49 PADI4 0.0033 8.7 5 338 48 27803 Polypharmacology Molecules Target Profile
50 NLRP3 0.011 8.3 4 338 40 27803 Polypharmacology Molecules Target Profile
51 CASP7 0.33 8.2 1 338 10 27803 Polypharmacology Molecules Target Profile
52 GAPDH 0.0012 8.2 6 338 61 27803 Polypharmacology Molecules Target Profile
53 NOD2 0.00066 7.6 7 338 77 27803 Polypharmacology Molecules Target Profile
54 RAPGEF3 0.12 7.5 2 338 22 27803 Polypharmacology Molecules Target Profile
55 BLM 0.0059 7.4 5 338 56 27803 Polypharmacology Molecules Target Profile
56 CASP1 0.044 7.3 3 338 34 27803 Polypharmacology Molecules Target Profile
57 PTPN5 0.12 7.2 2 338 23 27803 Polypharmacology Molecules Target Profile
58 RAD54L 0.37 6.9 1 338 12 27803 Polypharmacology Molecules Target Profile
59 PAFAH2 0.0037 6.5 6 338 77 27803 Polypharmacology Molecules Target Profile
60 TDP2 0.15 6.4 2 338 26 27803 Polypharmacology Molecules Target Profile
61 CDC42 0.38 6.3 1 338 13 27803 Polypharmacology Molecules Target Profile
62 ACP1 0.38 6.3 1 338 13 27803 Polypharmacology Molecules Target Profile
63 RORA 0.0106 6.2 5 338 67 27803 Polypharmacology Molecules Target Profile
64 NR5A1 0.00044 5.9 9 338 128 27803 Polypharmacology Molecules Target Profile
65 ATM 0.39 5.9 1 338 14 27803 Polypharmacology Molecules Target Profile
66 USP1 0.0063 5.8 6 338 87 27803 Polypharmacology Molecules Target Profile
67 ADRB2 0.033 5.7 4 338 58 27803 Polypharmacology Molecules Target Profile
68 NLRP1 0.033 5.7 4 338 58 27803 Polypharmacology Molecules Target Profile
69 TNF 0.014 5.7 5 338 73 27803 Polypharmacology Molecules Target Profile
70 AVPR1A 0.18 5.7 2 338 29 27803 Polypharmacology Molecules Target Profile
71 CFTR 0.0012 5.6 8 338 119 27803 Polypharmacology Molecules Target Profile
72 PAX8 0.033 5.6 4 338 59 27803 Polypharmacology Molecules Target Profile
73 PTK2 0.079 5.5 3 338 45 27803 Polypharmacology Molecules Target Profile
74 MAPK10 0.42 5.5 1 338 15 27803 Polypharmacology Molecules Target Profile
75 LYPLA2 0.088 5.3 3 338 47 27803 Polypharmacology Molecules Target Profile
76 NR2F2 0.044 5.1 4 338 65 27803 Polypharmacology Molecules Target Profile
77 NR2E3 0.044 5.1 4 338 65 27803 Polypharmacology Molecules Target Profile
78 APAF1 0.0106 5.1 6 338 99 27803 Polypharmacology Molecules Target Profile
79 L3MBTL1 0.029 4.7 5 338 89 27803 Polypharmacology Molecules Target Profile
80 SMARCA2 0.00404 4.6 8 338 145 27803 Polypharmacology Molecules Target Profile
81 HIF1A 0.11 4.6 3 338 54 27803 Polypharmacology Molecules Target Profile
82 JAK2 0.015 4.6 6 338 109 27803 Polypharmacology Molecules Target Profile
83 XBP1 0.49 4.6 1 338 18 27803 Polypharmacology Molecules Target Profile
84 BCL2A1 0.49 4.6 1 338 18 27803 Polypharmacology Molecules Target Profile
85 PPME1 0.032 4.6 5 338 91 27803 Polypharmacology Molecules Target Profile
86 TLR4 0.49 4.3 1 338 19 27803 Polypharmacology Molecules Target Profile
87 GALR2 0.077 4.2 4 338 80 27803 Polypharmacology Molecules Target Profile
88 NPSR1 0.013 4.1 7 338 142 27803 Polypharmacology Molecules Target Profile
89 ITGA4 0.28 4.0 2 338 41 27803 Polypharmacology Molecules Target Profile
90 GPR55 0.51 3.9 1 338 21 27803 Polypharmacology Molecules Target Profile
91 PREPL 0.091 3.9 4 338 86 27803 Polypharmacology Molecules Target Profile
92 S1PR3 0.53 3.7 1 338 22 27803 Polypharmacology Molecules Target Profile
93 GSTO1 0.065 3.6 5 338 115 27803 Polypharmacology Molecules Target Profile
94 RAPGEF4 0.54 3.6 1 338 23 27803 Polypharmacology Molecules Target Profile
95 GSK3A 0.54 3.6 1 338 23 27803 Polypharmacology Molecules Target Profile
96 CBX1 0.11 3.5 4 338 94 27803 Polypharmacology Molecules Target Profile
97 OXTR 0.33 3.4 2 338 48 27803 Polypharmacology Molecules Target Profile
98 S1PR2 0.33 3.4 2 338 48 27803 Polypharmacology Molecules Target Profile
99 TLR9 0.56 3.4 1 338 24 27803 Polypharmacology Molecules Target Profile
100 GPR183 0.085 3.3 5 338 125 27803 Polypharmacology Molecules Target Profile
101 IDE 0.33 3.3 2 338 50 27803 Polypharmacology Molecules Target Profile
102 NCF1 0.33 3.3 2 338 50 27803 Polypharmacology Molecules Target Profile
103 ATG4B 0.14 3.3 4 338 102 27803 Polypharmacology Molecules Target Profile
104 HNF4A 0.35 3.2 2 338 52 27803 Polypharmacology Molecules Target Profile
105 MBD2 0.57 3.2 1 338 26 27803 Polypharmacology Molecules Target Profile
106 S1PR4 0.37 3.1 2 338 54 27803 Polypharmacology Molecules Target Profile
107 MCOLN3 0.58 3.1 1 338 27 27803 Polypharmacology Molecules Target Profile
108 ABCB6 0.58 3.1 1 338 27 27803 Polypharmacology Molecules Target Profile
109 NR1I2 0.16 3.0 4 338 109 27803 Polypharmacology Molecules Target Profile
110 MPI 0.11 3.0 5 338 140 27803 Polypharmacology Molecules Target Profile
111 WHSC1 0.38 2.9 2 338 56 27803 Polypharmacology Molecules Target Profile
112 CASP6 0.58 2.9 1 338 28 27803 Polypharmacology Molecules Target Profile
113 F12 0.58 2.9 1 338 28 27803 Polypharmacology Molecules Target Profile
114 PAFAH1B2 0.18 2.9 4 338 114 27803 Polypharmacology Molecules Target Profile
115 CCR6 0.38 2.9 2 338 57 27803 Polypharmacology Molecules Target Profile
116 SMAD3 9.48e-06 2.9 32 338 977 27803 Polypharmacology Molecules Target Profile
117 PRNP 0.39 2.8 2 338 59 27803 Polypharmacology Molecules Target Profile
118 KLK7 0.206 2.8 4 338 120 27803 Polypharmacology Molecules Target Profile
119 PHOSPHO1 0.62 2.7 1 338 31 27803 Polypharmacology Molecules Target Profile
120 POLH 0.033 2.6 10 338 319 27803 Polypharmacology Molecules Target Profile
121 WRN 0.46 2.5 2 338 65 27803 Polypharmacology Molecules Target Profile
122 SUMO1 0.64 2.5 1 338 33 27803 Polypharmacology Molecules Target Profile
123 ATXN2 0.014 2.5 14 338 475 27803 Polypharmacology Molecules Target Profile
124 GLP1R 0.00093 2.5 25 338 875 27803 Polypharmacology Molecules Target Profile
125 POLK 0.27 2.5 4 338 135 27803 Polypharmacology Molecules Target Profile
126 AHR 0.038 2.4 11 338 380 27803 Polypharmacology Molecules Target Profile
127 TLR3 0.66 2.4 1 338 35 27803 Polypharmacology Molecules Target Profile
128 ADRBK1 0.49 2.3 2 338 71 27803 Polypharmacology Molecules Target Profile
129 WEE1 0.37 2.3 3 338 108 27803 Polypharmacology Molecules Target Profile
130 PLA2G1B 0.504 2.3 2 338 72 27803 Polypharmacology Molecules Target Profile
131 SIX1 0.504 2.3 2 338 72 27803 Polypharmacology Molecules Target Profile
132 MARVELD2 0.66 2.3 1 338 36 27803 Polypharmacology Molecules Target Profile
133 MAPT 0.0067 2.2 21 338 797 27803 Polypharmacology Molecules Target Profile
134 MCHR1 0.51 2.2 2 338 74 27803 Polypharmacology Molecules Target Profile
135 PKM 0.66 2.2 1 338 37 27803 Polypharmacology Molecules Target Profile
136 IL1B 0.033 2.2 14 338 534 27803 Polypharmacology Molecules Target Profile
137 VDR 0.28 2.1 5 338 195 27803 Polypharmacology Molecules Target Profile
138 COPS5 0.708 2.0 1 338 41 27803 Polypharmacology Molecules Target Profile
139 HTR1A 0.708 2.0 1 338 41 27803 Polypharmacology Molecules Target Profile
140 MC4R 0.32 2.0 5 338 210 27803 Polypharmacology Molecules Target Profile
141 CXCR6 0.71 2.0 1 338 42 27803 Polypharmacology Molecules Target Profile
142 HCRTR1 0.25 1.9 7 338 301 27803 Polypharmacology Molecules Target Profile
143 KCNJ1 0.49 1.9 3 338 129 27803 Polypharmacology Molecules Target Profile
144 ALPI 0.71 1.9 1 338 43 27803 Polypharmacology Molecules Target Profile
145 FEN1 0.58 1.9 2 338 88 27803 Polypharmacology Molecules Target Profile
146 SIRT5 0.71 1.9 1 338 44 27803 Polypharmacology Molecules Target Profile
147 AKT1 0.58 1.9 2 338 89 27803 Polypharmacology Molecules Target Profile
148 PIP4K2A 0.61 1.8 2 338 92 27803 Polypharmacology Molecules Target Profile
149 GFER 0.28 1.8 8 338 376 27803 Polypharmacology Molecules Target Profile
150 MRGPRX1 0.37 1.7 6 338 290 27803 Polypharmacology Molecules Target Profile
151 ARRB1 0.78 1.7 1 338 49 27803 Polypharmacology Molecules Target Profile
152 BCL2L1 0.66 1.6 2 338 101 27803 Polypharmacology Molecules Target Profile
153 APLNR 0.78 1.6 1 338 51 27803 Polypharmacology Molecules Target Profile
154 GAA 0.58 1.6 3 338 154 27803 Polypharmacology Molecules Target Profile
155 NPBWR1 0.58 1.6 3 338 156 27803 Polypharmacology Molecules Target Profile
156 TUBB 0.66 1.6 2 338 104 27803 Polypharmacology Molecules Target Profile
157 HPGD 0.33 1.6 9 338 473 27803 Polypharmacology Molecules Target Profile
158 DUSP3 0.66 1.6 2 338 105 27803 Polypharmacology Molecules Target Profile
159 RACGAP1 0.79 1.6 1 338 53 27803 Polypharmacology Molecules Target Profile
160 HTT 0.48 1.5 6 338 321 27803 Polypharmacology Molecules Target Profile
161 PLK1 0.39 1.5 8 338 433 27803 Polypharmacology Molecules Target Profile
162 PRMT1 0.61 1.5 3 338 162 27803 Polypharmacology Molecules Target Profile
163 PTGER2 0.62 1.5 3 338 163 27803 Polypharmacology Molecules Target Profile
164 DRD3 0.33 1.5 12 338 674 27803 Polypharmacology Molecules Target Profile
165 MAP4K2 0.66 1.5 3 338 170 27803 Polypharmacology Molecules Target Profile
166 POLI 0.504 1.4 7 338 405 27803 Polypharmacology Molecules Target Profile
167 PPP1CA 0.71 1.4 2 338 116 27803 Polypharmacology Molecules Target Profile
168 CHRM4 0.66 1.4 3 338 175 27803 Polypharmacology Molecules Target Profile
169 INS 0.66 1.4 3 338 177 27803 Polypharmacology Molecules Target Profile
170 RBBP8 0.84 1.4 1 338 59 27803 Polypharmacology Molecules Target Profile
171 NR5A2 0.84 1.4 1 338 59 27803 Polypharmacology Molecules Target Profile
172 TARDBP 0.28 1.4 22 338 1330 27803 Polypharmacology Molecules Target Profile
173 POLB 0.51 1.4 9 338 551 27803 Polypharmacology Molecules Target Profile
174 MAPK1 0.85 1.3 1 338 61 27803 Polypharmacology Molecules Target Profile
175 HTR1E 0.87 1.3 1 338 62 27803 Polypharmacology Molecules Target Profile
176 APOBEC3F 0.708 1.3 3 338 187 27803 Polypharmacology Molecules Target Profile
177 NPY1R 0.71 1.3 3 338 193 27803 Polypharmacology Molecules Target Profile
178 TSHR 0.79 1.3 2 338 130 27803 Polypharmacology Molecules Target Profile
179 NPY2R 0.75 1.3 3 338 197 27803 Polypharmacology Molecules Target Profile
180 FGF22 0.89 1.2 1 338 66 27803 Polypharmacology Molecules Target Profile
181 KCNH2 0.89 1.2 1 338 66 27803 Polypharmacology Molecules Target Profile
182 EHMT2 0.33 1.2 38 338 2570 27803 Polypharmacology Molecules Target Profile
183 CYP2C19 0.92 1.2 1 338 69 27803 Polypharmacology Molecules Target Profile
184 THRB 0.71 1.2 6 338 420 27803 Polypharmacology Molecules Target Profile
185 BRCA1 0.809 1.2 3 338 213 27803 Polypharmacology Molecules Target Profile
186 NFE2L2 0.61 1.2 18 338 1288 27803 Polypharmacology Molecules Target Profile
187 DRD1 0.56 1.1 33 338 2405 27803 Polypharmacology Molecules Target Profile
188 SLC5A7 0.84 1.1 3 338 225 27803 Polypharmacology Molecules Target Profile
189 DRD2 0.78 1.1 8 338 611 27803 Polypharmacology Molecules Target Profile
190 PSMD14 0.97 1.0 1 338 79 27803 Polypharmacology Molecules Target Profile
191 SELE 0.97 1.0 1 338 79 27803 Polypharmacology Molecules Target Profile
192 KCNQ1 0.96 1.0 3 338 255 27803 Polypharmacology Molecules Target Profile
193 BAZ2B 0.94 1.0 19 338 1617 27803 Polypharmacology Molecules Target Profile
194 TRHR 0.96 0.9 5 338 433 27803 Polypharmacology Molecules Target Profile
195 MCL1 0.96 0.9 4 338 350 27803 Polypharmacology Molecules Target Profile
196 CTDSP1 0.99 0.9 1 338 88 27803 Polypharmacology Molecules Target Profile
197 ALDH1A1 0.99 0.9 9 338 808 27803 Polypharmacology Molecules Target Profile
198 FASN 0.99 0.9 1 338 93 27803 Polypharmacology Molecules Target Profile
199 TAAR1 0.99 0.9 3 338 283 27803 Polypharmacology Molecules Target Profile
200 APOBEC3G 0.99 0.8 2 338 203 27803 Polypharmacology Molecules Target Profile
201 DNMT1 0.99 0.8 1 338 107 27803 Polypharmacology Molecules Target Profile
202 SLC12A5 0.99 0.8 2 338 217 27803 Polypharmacology Molecules Target Profile
203 PTBP1 0.99 0.7 9 338 998 27803 Polypharmacology Molecules Target Profile
204 ABCC1 0.99 0.7 1 338 117 27803 Polypharmacology Molecules Target Profile
205 SLC6A3 0.99 0.7 1 338 121 27803 Polypharmacology Molecules Target Profile
206 PLCG1 0.99 0.7 1 338 122 27803 Polypharmacology Molecules Target Profile
207 CACNA1H 0.99 0.6 3 338 397 27803 Polypharmacology Molecules Target Profile
208 RXFP1 0.99 0.6 3 338 400 27803 Polypharmacology Molecules Target Profile
209 KCNK3 0.99 0.6 1 338 136 27803 Polypharmacology Molecules Target Profile
210 CHRM5 0.99 0.5 1 338 153 27803 Polypharmacology Molecules Target Profile
211 TDP1 0.99 0.5 133 338 15692 27803 Polypharmacology Molecules Target Profile
212 PLA2G7 0.99 0.5 1 338 173 27803 Polypharmacology Molecules Target Profile
213 ESR1 0.99 0.5 1 338 177 27803 Polypharmacology Molecules Target Profile
214 KCNK9 0.99 0.3 1 338 235 27803 Polypharmacology Molecules Target Profile
215 MAP3K3 0.99 0.2 1 338 388 27803 Polypharmacology Molecules Target Profile
216 GSK3B 0.99 0.0 0 338 19 27803 Polypharmacology Molecules Target Profile
217 SNCA 0.99 0.0 0 338 32 27803 Polypharmacology Molecules Target Profile
218 PLCB3 0.99 0.0 0 338 42 27803 Polypharmacology Molecules Target Profile
219 ALOX15 0.99 0.0 0 338 25 27803 Polypharmacology Molecules Target Profile
220 CLK1 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
221 EIF4H 0.99 0.0 0 338 85 27803 Polypharmacology Molecules Target Profile
222 CGA 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
223 RBBP9 0.99 0.0 0 338 23 27803 Polypharmacology Molecules Target Profile
224 BCL2L10 0.99 0.0 0 338 8 27803 Polypharmacology Molecules Target Profile
225 RXFP2 0.99 0.0 0 338 9 27803 Polypharmacology Molecules Target Profile
226 CYP2C9 0.99 0.0 0 338 82 27803 Polypharmacology Molecules Target Profile
227 GNAO1 0.99 0.0 0 338 93 27803 Polypharmacology Molecules Target Profile
228 TP53 0. 0.0 338 338 1045 27803 Polypharmacology Molecules Target Profile
229 HDAC3 0.99 0.0 0 338 14 27803 Polypharmacology Molecules Target Profile
230 GLS 0.99 0.0 0 338 50 27803 Polypharmacology Molecules Target Profile
231 CHRM1 0.99 0.0 0 338 193 27803 Polypharmacology Molecules Target Profile
232 RELA 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
233 FPR1 0.99 0.0 0 338 11 27803 Polypharmacology Molecules Target Profile
234 BCL2 0.99 0.0 0 338 6 27803 Polypharmacology Molecules Target Profile
235 KAT2A 0.99 0.0 0 338 50 27803 Polypharmacology Molecules Target Profile
236 RGS7 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
237 YWHAG 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
238 PTPN11 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
239 RAC1 0.99 0.0 0 338 22 27803 Polypharmacology Molecules Target Profile
240 PTH1R 0.99 0.0 0 338 71 27803 Polypharmacology Molecules Target Profile
241 ABCB1 0.99 0.0 0 338 9 27803 Polypharmacology Molecules Target Profile
242 ERAP1 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
243 MMP13 0.99 0.0 0 338 6 27803 Polypharmacology Molecules Target Profile
244 GBA 0.99 0.0 0 338 28 27803 Polypharmacology Molecules Target Profile
245 KLK5 0.99 0.0 0 338 55 27803 Polypharmacology Molecules Target Profile
246 USP2 0.99 0.0 0 338 13 27803 Polypharmacology Molecules Target Profile
247 RAD52 0.99 0.0 0 338 14 27803 Polypharmacology Molecules Target Profile
248 CTNNB1 0.99 0.0 0 338 42 27803 Polypharmacology Molecules Target Profile
249 KPNA2 0.99 0.0 0 338 19 27803 Polypharmacology Molecules Target Profile
250 C1S 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
251 DLD 0.99 0.0 0 338 65 27803 Polypharmacology Molecules Target Profile
252 EPHB4 0.99 0.0 0 338 9 27803 Polypharmacology Molecules Target Profile
253 ADAM10 0.99 0.0 0 338 125 27803 Polypharmacology Molecules Target Profile
254 HTR5A 0.99 0.0 0 338 103 27803 Polypharmacology Molecules Target Profile
255 PLEC 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
256 MDM2 0.99 0.0 0 338 14 27803 Polypharmacology Molecules Target Profile
257 ALPPL2 0.99 0.0 0 338 16 27803 Polypharmacology Molecules Target Profile
258 VCAM1 0.99 0.0 0 338 8 27803 Polypharmacology Molecules Target Profile
259 RAD51 0.99 0.0 0 338 6 27803 Polypharmacology Molecules Target Profile
260 RGS4 0.99 0.0 0 338 202 27803 Polypharmacology Molecules Target Profile
261 ALPL 0.99 0.0 0 338 42 27803 Polypharmacology Molecules Target Profile
262 AVPR1B 0.99 0.0 0 338 9 27803 Polypharmacology Molecules Target Profile
263 FKBP1A 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
264 GALR3 0.99 0.0 0 338 60 27803 Polypharmacology Molecules Target Profile
265 GNAS 0.99 0.0 0 338 30 27803 Polypharmacology Molecules Target Profile
266 RCE1 0.99 0.0 0 338 11 27803 Polypharmacology Molecules Target Profile
267 UBE2N 0.99 0.0 0 338 35 27803 Polypharmacology Molecules Target Profile
268 F2 0.99 0.0 0 338 32 27803 Polypharmacology Molecules Target Profile
269 STK33 0.99 0.0 0 338 22 27803 Polypharmacology Molecules Target Profile
270 OPRK1 0.99 0.0 0 338 8 27803 Polypharmacology Molecules Target Profile
271 RGS16 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
272 HSPA5 0.99 0.0 0 338 12 27803 Polypharmacology Molecules Target Profile
273 TSG101 0.99 0.0 0 338 11 27803 Polypharmacology Molecules Target Profile
274 F11 0.99 0.0 0 338 21 27803 Polypharmacology Molecules Target Profile
275 APOBEC3A 0.99 0.0 0 338 45 27803 Polypharmacology Molecules Target Profile
276 HRAS 0.99 0.0 0 338 13 27803 Polypharmacology Molecules Target Profile
277 ABCG2 0.99 0.0 0 338 35 27803 Polypharmacology Molecules Target Profile
278 UHRF1 0.99 0.0 0 338 68 27803 Polypharmacology Molecules Target Profile
279 MAP1LC3A 0.99 0.0 0 338 148 27803 Polypharmacology Molecules Target Profile
280 TRA@ 0.99 0.0 0 338 31 27803 Polypharmacology Molecules Target Profile
281 MCOLN1 0.99 0.0 0 338 80 27803 Polypharmacology Molecules Target Profile
282 PABPC1 0.99 0.0 0 338 123 27803 Polypharmacology Molecules Target Profile
283 DRD5 0.99 0.0 0 338 9 27803 Polypharmacology Molecules Target Profile
284 PLA2G3 0.99 0.0 0 338 86 27803 Polypharmacology Molecules Target Profile
285 GSTM1 0.99 0.0 0 338 6 27803 Polypharmacology Molecules Target Profile
286 TRPV1 0.99 0.0 0 338 28 27803 Polypharmacology Molecules Target Profile
287 EIF2AK3 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
288 MLLT3 0.99 0.0 0 338 22 27803 Polypharmacology Molecules Target Profile
289 CTBP1 0.99 0.0 0 338 13 27803 Polypharmacology Molecules Target Profile
290 LARGE 0.99 0.0 0 338 31 27803 Polypharmacology Molecules Target Profile
291 ADORA2A 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
292 GPR35 0.99 0.0 0 338 5 27803 Polypharmacology Molecules Target Profile
293 PRKACA 0.99 0.0 0 338 6 27803 Polypharmacology Molecules Target Profile
294 ADAM17 0.99 0.0 0 338 145 27803 Polypharmacology Molecules Target Profile
295 GNA15 0.99 0.0 0 338 99 27803 Polypharmacology Molecules Target Profile
296 HTR6 0.99 0.0 0 338 38 27803 Polypharmacology Molecules Target Profile
297 ESR2 0.99 0.0 0 338 77 27803 Polypharmacology Molecules Target Profile
298 ASAP1 0.99 0.0 0 338 13 27803 Polypharmacology Molecules Target Profile
299 ALOX12 0.99 0.0 0 338 16 27803 Polypharmacology Molecules Target Profile
300 BCL2L2 0.99 0.0 0 338 6 27803 Polypharmacology Molecules Target Profile
301 NFKBIA 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
302 FPR2 0.99 0.0 0 338 13 27803 Polypharmacology Molecules Target Profile
303 MMP2 0.99 0.0 0 338 9 27803 Polypharmacology Molecules Target Profile
304 CCT2 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
305 PLIN1 0.99 0.0 0 338 4 27803 Polypharmacology Molecules Target Profile
306 EPHX2 0.99 0.0 0 338 24 27803 Polypharmacology Molecules Target Profile
307 NTSR1 0.99 0.0 0 338 24 27803 Polypharmacology Molecules Target Profile